{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:38:17Z","timestamp":1791405497044,"version":"4.3.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11136-020-02492-8","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T06:02:22Z","timestamp":1586584942000},"page":"2403-2414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A qualitative inquiry into patients\u2019 perspectives on individualized priorities for treatment outcomes in inflammatory bowel diseases"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-9849","authenticated-orcid":false,"given":"Welmoed K.","family":"van Deen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Kiaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Alandra","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damara J.","family":"Crate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil Y.","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"issue":"3","key":"2492_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","volume":"10","author":"D Farrell","year":"2016","unstructured":"Farrell, D., McCarthy, G., & Savage, E. (2016). Self-reported symptom burden in individuals with inflammatory bowel disease. Journal of Crohn's and Colitis, 10(3), 315\u2013322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv218.","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"2492_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/MIB.0000000000001060","volume":"23","author":"WW IsHak","year":"2017","unstructured":"IsHak, W. W., Pan, D., Steiner, A. J., Feldman, E., Mann, A., Mirocha, J., et al. (2017). Patient-reported outcomes of quality of life, functioning, and GI\/psychiatric symptom severity in patients with inflammatory bowel disease (IBD). Inflammatory Bowel Diseases, 23(5), 798\u2013803. https:\/\/doi.org\/10.1097\/MIB.0000000000001060.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"12","key":"2492_CR3","first-page":"24","volume":"91","author":"ME Porter","year":"2013","unstructured":"Porter, M. E., & Lee, T. H. (2013). The strategy that will fix health care. Harvard Business Review, 91(12), 24\u201324.","journal-title":"Harvard Business Review"},{"key":"2492_CR4","doi-asserted-by":"publisher","first-page":"i3319","DOI":"10.1136\/bmj.i3319","volume":"354","author":"EC Nelson","year":"2016","unstructured":"Nelson, E. C., Dixon-Woods, M., Batalden, P. B., Homa, K., Van Citters, A. D., Morgan, T. S., et al. (2016). Patient focused registries can improve health, care, and science. BMJ, 354, i3319.","journal-title":"BMJ"},{"issue":"2","key":"2492_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/diaspect.17.2.97","volume":"17","author":"AD Association","year":"2004","unstructured":"Association, A. D. (2004). The breakthrough series: IHI\u2019s collaborative model for achieving breakthrough improvement. Diabetes Spectrum, 17(2), 97\u2013101.","journal-title":"Diabetes Spectrum"},{"issue":"3","key":"2492_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/ecco-jcc\/jjv002","volume":"9","author":"L Alrubaiy","year":"2015","unstructured":"Alrubaiy, L., Rikaby, I., Dodds, P., Hutchings, H. A., & Williams, J. G. (2015). Systematic review of health-related quality of life measures for inflammatory bowel disease. Journal of Crohn's and Colitis, 9(3), 284\u2013292. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv002.","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10","key":"2492_CR7","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1097\/MIB.0000000000000438","volume":"21","author":"L Alrubaiy","year":"2015","unstructured":"Alrubaiy, L., Rikaby, I., Sageer, M., Hutchings, H. A., & Williams, J. G. (2015). Systematic review of the clinical disease severity indices for inflammatory bowel disease. Inflammatory Bowel Diseases, 21(10), 2460\u20132466. https:\/\/doi.org\/10.1097\/MIB.0000000000000438.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"2492_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","volume":"16","author":"MJ de Jong","year":"2018","unstructured":"de Jong, M. J., Huibregtse, R., Masclee, A. A. M., Jonkers, D. M. A. E., & Pierik, M. J. (2018). Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: A systematic review. Clinical Gastroenterology and Hepatology, 16(5), 648\u2013663.e643. https:\/\/doi.org\/10.1016\/j.cgh.2017.10.019.","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"2492_CR9","doi-asserted-by":"publisher","first-page":"e0171864","DOI":"10.1371\/journal.pone.0171864","volume":"12","author":"V Pittet","year":"2017","unstructured":"Pittet, V., Vaucher, C., Froehlich, F., Burnand, B., Michetti, P., Maillard, M. H., et al. (2017). Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS ONE, 12(2), e0171864. https:\/\/doi.org\/10.1371\/journal.pone.0171864.","journal-title":"PLoS ONE"},{"issue":"2","key":"2492_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/000841740206900204","volume":"69","author":"C Donnelly","year":"2002","unstructured":"Donnelly, C., & Carswell, A. (2002). Individualized outcome measures: A review of the literature. Canadian Journal of Occupational Therapy, 69(2), 84\u201394. https:\/\/doi.org\/10.1177\/000841740206900204.","journal-title":"Canadian Journal of Occupational Therapy"},{"issue":"9","key":"2492_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMp1113631","volume":"366","author":"DB Reuben","year":"2012","unstructured":"Reuben, D. B., & Tinetti, M. E. (2012). Goal-oriented patient care\u2014An alternative health outcomes paradigm. The New England Journal of Medicine, 366(9), 777\u2013779. https:\/\/doi.org\/10.1056\/NEJMp1113631.","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"2492_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1524-4733.2003.65236.x","volume":"6","author":"KK Patel","year":"2003","unstructured":"Patel, K. K., Veenstra, D. L., & Patrick, D. L. (2003). A review of selected patient-generated outcome measures and their application in clinical trials. Value Health, 6(5), 595\u2013603. https:\/\/doi.org\/10.1046\/j.1524-4733.2003.65236.x.","journal-title":"Value Health"},{"issue":"1\u20132","key":"2492_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/A:1026485130100","volume":"8","author":"C Bradley","year":"1999","unstructured":"Bradley, C., Todd, C., Gorton, T., Symonds, E., Martin, A., & Plowright, R. (1999). The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Quality of Life Research, 8(1\u20132), 79\u201391.","journal-title":"Quality of Life Research"},{"issue":"3","key":"2492_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1017\/S0033291700022388","volume":"21","author":"HM McGee","year":"1991","unstructured":"McGee, H. M., O'Boyle, C. A., Hickey, A., O'Malley, K., & Joyce, C. R. (1991). Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychological Medicine, 21(3), 749\u2013759.","journal-title":"Psychological Medicine"},{"issue":"1","key":"2492_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/qshc.8.1.22","volume":"8","author":"DA Ruta","year":"1999","unstructured":"Ruta, D. A., Garratt, A. M., & Russell, I. T. (1999). Patient centred assessment of quality of life for patients with four common conditions. Quality in Health Care, 8(1), 22\u201329.","journal-title":"Quality in Health Care"},{"key":"2492_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/00005650-199411000-00004","volume":"32","author":"DA Ruta","year":"1994","unstructured":"Ruta, D. A., Garratt, A. M., Leng, M., Russell, I. T., & MacDonald, L. M. (1994). A new approach to the measurement of quality of life: The Patient-Generated Index. Medical Care, 32, 1109\u20131126.","journal-title":"Medical Care"},{"issue":"4","key":"2492_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski, M. (2000). Whatever happened to qualitative description? Research in Nursing & Health, 23(4), 334\u2013340.","journal-title":"Research in Nursing & Health"},{"issue":"1","key":"2492_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-9-52","volume":"9","author":"MA Neergaard","year":"2009","unstructured":"Neergaard, M. A., Olesen, F., Andersen, R. S., & Sondergaard, J. (2009). Qualitative description\u2013The poor cousin of health research? BMC Medical Research Methodology, 9(1), 52.","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"2492_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/nur.21768","volume":"40","author":"H Kim","year":"2017","unstructured":"Kim, H., Sefcik, J. S., & Bradway, C. (2017). Characteristics of qualitative descriptive studies: A systematic review. Research in Nursing & Health, 40(1), 23\u201342.","journal-title":"Research in Nursing & Health"},{"key":"2492_CR20","volume-title":"Qualitative research","author":"MQ Patton","year":"2005","unstructured":"Patton, M. Q. (2005). Qualitative research. New York: Wiley Online Library."},{"issue":"3","key":"2492_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/mib.0b013e31828278a2","volume":"19","author":"GY Melmed","year":"2013","unstructured":"Melmed, G. Y., Siegel, C. A., Spiegel, B. M., Allen, J. I., Cima, R., Colombel, J. F., et al. (2013). Quality indicators for inflammatory bowel disease: Development of process and outcome measures. Inflammatory Bowel Diseases, 19(3), 662\u2013668. https:\/\/doi.org\/10.1097\/mib.0b013e31828278a2.","journal-title":"Inflammatory Bowel Diseases"},{"key":"2492_CR22","unstructured":"O'Boyle, C. A., Browne, J., Hickey, A., McGee, H. M., & Joyce, C. R. B. (1993). The schedule for the evaluation of individual quality of life (SEIQoL): A direct weighting procedure for quality of life domains (SEIQoL-DW) Administration Manual."},{"issue":"3","key":"2492_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/00207411.1994.11449285","volume":"23","author":"CA O\u2019Boyle","year":"1994","unstructured":"O\u2019Boyle, C. A. (1994). The schedule for the evaluation of individual quality of life (SEIQoL). International Journal of Mental Health, 23(3), 3\u201323.","journal-title":"International Journal of Mental Health"},{"issue":"2","key":"2492_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77\u2013101.","journal-title":"Qualitative Research in Psychology"},{"issue":"1","key":"2492_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"FR Johnson","year":"2013","unstructured":"Johnson, F. R., Lancsar, E., Marshall, D., Kilambi, V., M\u00fchlbacher, A., Regier, D. A., et al. (2013). Constructing experimental designs for discrete-choice experiments: Report of the ISPOR conjoint analysis experimental design good research practices task force. Value in Health, 16(1), 3\u201313.","journal-title":"Value in Health"},{"issue":"6","key":"2492_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/hec.845","volume":"13","author":"TL Mark","year":"2004","unstructured":"Mark, T. L., & Swait, J. (2004). Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Economics, 13(6), 563\u2013573.","journal-title":"Health Economics"},{"issue":"3","key":"2492_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/gutjnl-2011-300988","volume":"61","author":"CA Siegel","year":"2012","unstructured":"Siegel, C. A. (2012). Shared decision making in inflammatory bowel disease: Helping patients understand the tradeoffs between treatment options. Gut, 61(3), 459\u2013465.","journal-title":"Gut"},{"issue":"9","key":"2492_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet, L., Sandborn, W., Sands, B., Reinisch, W., Bemelman, W., Bryant, R., et al. (2015). Selecting therapeutic targets in inflammatory bowel disease (STRIDE): Determining therapeutic goals for treat-to-target. The American Journal of Gastroenterology, 110(9), 1324.","journal-title":"The American Journal of Gastroenterology"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-020-02492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-020-02492-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-020-02492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T23:07:15Z","timestamp":1618096035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-020-02492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2492"],"URL":"https:\/\/doi.org\/10.1007\/s11136-020-02492-8","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,11]]},"assertion":[{"value":"25 March 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"WKvD: Grant Funding from Crohn's and Colitis Foundation; SAW: Employee of the Crohn\u2019s and Colitis Foundation; GYM: Consultant: Abbvie, Boehringer-Ingelheim, Celgene, Janssen, Pfizer, Samsung Bioepis, Takeda; CAS: Consultant\/Advisory Board: Abbvie, Amgen, BMS, Celgene, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Sebela, Takeda; Speaker for CME activities: Abbvie, Celgene, Janssen, Pfizer, Takeda; Grant support: Crohn\u2019s and Colitis Foundation, AHRQ (1R01HS021747-01), Broad Medical Research Program, Abbvie, Janssen, Pfizer, Takeda; Intellectual property: MiTest Health, LLC has a patent pending for a \u201cSystem and Method of Communicating Predicted Medical Outcomes\u201d, filed 3\/24\/10. Dr. Corey Siegel and Dr. Lori Siegel are inventors; Equity Interest: Dr. Corey Siegel and Dr. Lori Siegel are co-founders of MiTest Health, LLC. BK, DJC, MHK and SAS do not have any financial disclosures or conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board (IRB) approval was obtained for all participating sites: Gastroenterology Associates relied on the University of Southern California IRB under protocol number HS-18-00424. The Cedars-Sinai Medical Center IRB approved this under protocol number Pro00054443 and the Dartmouth-Hitchcock Medical Center approved it under protocol number STUDY00031555. All procedures performed in studies involving human participants were in accordance with the ethical standards of these IRBs and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants were provided with an information sheet and verbally consented to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}